hsa05200:pathways in cancer |
73 |
1.09E-32 |
P24385, P42224, Q13043, Q92769, P16234, Q01970, P10398, P84022, Q12778, P42229, P11274, Q00987, P16885, P38936, P17612, P55211, P10415, P15056, P06400, P05556, P49841, Q92934, P25963, P24864, P00519, P05771, P63000, P04637, P08069, P05412, Q07817, P08238, P98170, Q04206, P55957, P60484, P46527, P07333, P11362, P08581, O14920, P17252, Q02750, P35222, O75030, O15111, Q13547, P10275, P09619, P51692, P04626, P31751, Q13158, P01106, P42345, P37231, P01100, Q9Y6K9, P46108, P07949, P23458, P19174, P19838, P24941, O15392, P10721, P04049, Q15796, Q05397, P42574, P00533, P40763, P31749
|
1.36E-29 |
hsa04012:ErbB signaling pathway |
39 |
2.16E-32 |
P12931, P23443, P19419, P17252, Q02750, P10398, P42229, P42684, P16885, P51692, P04626, Q9UQM7, P31751, P38936, P01106, P42345, O75914, P46108, P29353, P15056, Q13153, P49841, Q92934, P19174, Q13541, P05771, P00519, Q13177, Q13480, P04049, P05412, Q05397, P45985, P21860, P00533, O14733, Q9UBS0, P46527, P31749
|
2.70E-29 |
hsa05215:prostate cancer |
39 |
3.68E-32 |
P24385, P11362, O14920, P16234, Q02750, P10398, Q12778, P35222, O15111, P10275, Q00987, O15530, P09619, P04626, P31751, P38936, P42345, Q9Y6K9, P55211, P10415, P15056, P06400, P18848, P49841, Q92934, P25963, P24864, P19838, P24941, P16220, P04637, P04049, P08069, P08238, Q04206, P60484, P00533, P46527, P31749
|
4.60E-29 |
hsa04151:PI3K-Akt signaling pathway |
68 |
6.55E-32 |
P24385, P16234, P49815, P62753, P35568, O15530, Q00987, P38936, P55211, P10415, O43521, Q16543, P24394, P05556, P49841, Q92934, P24864, P17948, P05106, O43524, P63000, P16220, P04637, P08069, Q07817, P35968, P08238, Q04206, P26951, P01589, P60484, Q9UBS0, P46527, Q15831, P07333, P23443, P11362, P08581, O14920, P17252, Q02750, O15111, O60674, P38398, P09619, P29474, P31751, P43405, P01106, P42345, P30281, Q9Y6K9, P63104, Q13131, P23458, P18848, Q13541, P16144, P15336, P19838, P24941, P06730, P10721, P04049, P19235, Q05397, P00533, P31749
|
8.20E-29 |
hsa05161:hepatitis B |
45 |
1.88E-29 |
P24385, P42224, P12931, Q14289, P19419, P17252, O14920, Q02750, P42226, P42229, O15111, P51692, P31751, Q13158, P38936, P01106, Q12968, P01100, Q9Y6K9, P55211, P10415, P63104, P06400, P23458, P18848, Q92934, P25963, P24864, P15336, P05771, P19838, P24941, P16220, P04637, O15392, P04049, P05412, P52630, Q04206, P45985, P42574, P60484, P46527, P31749, P40763
|
2.36E-26 |
hsa05205:proteoglycans in cancer |
50 |
5.08E-28 |
P24385, P12931, P19419, P62753, P10398, Q03135, P62136, P15311, Q00987, O15530, P16885, Q9UQM7, P38936, P17612, P15056, P05556, Q13153, P21333, P17844, P05771, P05106, P63000, P04637, P08069, P35968, Q16539, Q9UBS0, P23443, P11362, P08581, P17252, Q02750, P35222, P04626, Q06124, P31751, P01106, P42345, P19174, Q13480, P04049, P03372, P49023, Q05397, P21860, P42574, P00533, P31749, P40763, Q14247
|
6.36E-25 |
hsa04010:MAPK signaling pathway |
55 |
1.69E-27 |
Q13043, P19419, P16234, P28562, O43318, Q99683, P30305, P17612, P15056, Q13153, Q9BUB5, P21333, P05771, P47712, P63000, P04637, Q15418, P05412, Q01201, P16949, Q04206, P45985, Q16539, P04792, P49407, P11362, O14920, P17252, Q02750, O15111, P09619, P31751, P17535, P01106, Q12968, P11831, P01100, P46108, Q9Y6K9, P46734, P41279, P10636, P18848, Q13972, P15336, P19838, Q13177, P04049, Q16620, Q06413, P42574, O75582, O14733, P00533, P31749
|
2.12E-24 |
hsa04722:neurotrophin signaling pathway |
39 |
3.04E-26 |
P52565, O14920, Q02750, P35568, P62158, O15530, Q99683, P16885, Q06124, Q9UQM7, P31751, O00221, P46108, P29353, P10415, P15056, P18848, Q15653, P49841, Q92934, P25963, P19174, Q05655, P19838, P00519, Q16566, P63000, O43524, P04637, Q13480, Q15418, P04049, P05412, Q16620, Q04206, O75582, Q16539, O14733, P31749
|
3.80E-23 |
hsa05220:chronic myeloid leukemia |
31 |
5.91E-25 |
P24385, Q92769, O14920, Q02750, P10398, P42229, O15111, Q13547, P11274, Q00987, P51692, Q06124, P31751, P38936, P01106, Q9Y6K9, P46108, P29353, P15056, P06400, Q9UQC2, Q92934, P25963, P19838, P00519, P04637, P04049, Q07817, Q04206, P46527, P31749
|
7.40E-22 |
hsa04014:Ras signaling pathway |
49 |
1.76E-24 |
Q13043, P07333, P19419, P11362, P17252, P08581, O14920, Q05586, P16234, Q02750, O15111, P62158, P42684, P09619, P43403, P16885, P31751, Q06124, P17612, O75914, P98177, Q9Y6K9, P29353, Q04864, Q9UQC2, Q13153, Q92934, Q13972, P19174, P17948, P05771, P19838, Q13177, P00519, O43561, P47712, P63000, P10721, Q13480, P04049, P08069, Q13393, Q07817, P35968, Q04206, Q8IVT5, Q13224, P00533, P31749
|
2.20E-21 |
hsa04510:focal adhesion |
46 |
1.70E-23 |
P24385, P18206, P12931, P19419, P17252, P08581, P16234, Q02750, P35222, Q03135, P62136, P56945, O15530, P09619, P04626, P31751, P30281, O75914, P46108, P29353, P10415, P15056, P05556, Q13153, Q92934, P49841, Q13972, P52735, P21333, P16144, P17948, P05771, Q13177, P05106, P63000, P04049, P08069, P05412, P35968, P50552, Q05397, P49023, P98170, P60484, P00533, P31749
|
2.13E-20 |
hsa05169:Epstein-Barr virus infection |
44 |
4.09E-23 |
Q92769, O14920, P67870, O15111, Q13547, O43318, Q00987, P16885, P56524, Q13651, P43405, P31751, P38936, P01106, P17612, O00221, Q9Y6K9, P46734, P10415, P63104, P07948, P06400, P23458, Q15653, P49841, P05362, P25963, P19525, P15336, P19174, P19838, P24941, P04637, P05412, Q01201, Q9UQL6, Q04206, P45985, Q16539, O14733, P04792, P40763, P46527, P31749
|
5.11E-20 |
hsa04660:T cell receptor signaling pathway |
33 |
6.49E-22 |
P20963, P06239, P01730, O14920, Q02750, O15111, O43318, Q13094, O15530, P43403, P31751, Q12968, O75914, P01100, O00221, Q9Y6K9, P41279, Q13153, Q15653, P49841, P25963, P52735, P19174, P19838, Q13177, O43561, P04049, P05412, Q04759, Q04206, Q16539, O14733, P31749
|
8.12E-19 |
hsa04380:osteoclast differentiation |
36 |
1.81E-21 |
P17275, P06239, P42224, P07333, O14920, Q02750, Q06187, O75030, O15111, O43318, Q13094, P16885, P43405, P31751, P17535, P37231, P01100, Q9Y6K9, P15260, Q9UQC2, P23458, P25963, P19838, P05106, Q16566, Q8WV28, P16220, P63000, P05412, Q01201, P52630, Q04206, Q16539, P53539, O14733, P31749
|
2.27E-18 |
hsa05203:viral carcinogenesis |
41 |
4.83E-19 |
P24385, P12931, Q92769, Q9UBN7, O15379, P42229, Q13547, Q00987, P56524, P51692, P43405, P38936, P17612, P11831, P30281, Q9Y6K9, P63104, P07948, Q04864, P06400, O14757, P23458, P18848, Q92934, P25963, P24864, P19525, P15336, P19838, P24941, P16220, P63000, P04637, P05412, P49023, Q9UQL6, Q9BY41, Q04206, P42574, P46527, P40763
|
6.04E-16 |
hsa05212:pancreatic cancer |
25 |
1.12E-18 |
P06400, P24385, P42224, P23458, Q92934, O14920, Q02750, P19838, P10398, P84022, O15111, P63000, P04637, P04049, Q07817, Q15796, P04626, P31751, Q04206, P00533, Q9Y6K9, P55211, P31749, P40763, P15056
|
1.41E-15 |
hsa04666:Fc gamma R-mediated phagocytosis |
27 |
6.21E-18 |
P23443, P17252, Q02750, P23528, Q02156, P16885, P53667, P43405, P31751, P29966, P08631, P46108, P07948, Q9UQC2, Q13153, P52735, P19174, P05771, Q05655, O43561, P63000, P04049, Q92558, Q13393, P50552, Q9UBS0, P31749
|
7.77E-15 |
hsa05214:glioma |
24 |
1.85E-17 |
P06400, P24385, P17252, P16234, P19174, Q02750, P05771, P10398, P62158, P04637, P08069, P04049, Q00987, P09619, P16885, P31751, Q9UQM7, P38936, P42345, P60484, P00533, P31749, P29353, P15056
|
2.31E-14 |
hsa04919:thyroid hormone signaling pathway |
30 |
2.67E-17 |
P24385, P42224, P12931, Q92769, P17252, O15379, P49815, Q01970, Q02750, Q12778, P35222, Q13547, O15530, Q00987, P16885, P31751, P01106, P17612, P42345, P55211, P49841, Q92934, P19174, P05771, P05106, P04637, P04049, P03372, P31749, Q15648
|
3.34E-14 |
hsa04062:chemokine signaling pathway |
37 |
4.36E-17 |
P42224, P12931, Q14289, O14920, Q01970, Q02750, O15111, P56945, O60674, P51692, P31751, P08631, P17612, P46108, Q9Y6K9, P29353, P25098, P15056, P07948, Q13153, Q15653, P49841, P25963, P52735, Q05655, P19838, P63000, O43524, P04049, Q05397, P49023, P52630, Q04206, P49407, P31749, P40763, Q05513
|
5.45E-14 |
hsa05221:acute myeloid leukemia |
22 |
1.22E-16 |
P24385, Q92934, P23443, O14920, Q13541, Q02750, P19838, P10398, P42229, O15111, P10721, P04049, P51692, P31751, Q04206, P01106, P42345, Q9Y6K9, Q9UBS0, P31749, P40763, P15056
|
1.44E-13 |
hsa04068:FoxO signaling pathway |
31 |
3.33E-16 |
P24385, Q15831, Q13043, O14920, Q02750, P04040, P10398, P35568, Q12778, P84022, O15111, Q00987, O15530, P31751, P38936, P98177, P15056, Q13131, O43521, P24941, O43524, P14635, P04049, P08069, Q15796, P60484, Q16539, P00533, P40763, P46527, P31749
|
4.22E-13 |
hsa05166:HTLV-I infection |
42 |
3.86E-16 |
P24385, P06239, P19419, O14920, P16234, P84022, P35222, P42229, O15111, P09619, P51692, P31751, P38936, P01106, P17612, P11831, Q12968, P30281, P01100, Q9Y6K9, P06400, O14757, P18846, P23458, P18848, P49841, P05362, P25963, P15336, O96017, P19838, P16220, P04637, P05412, Q07817, Q15796, Q01201, Q04206, P98170, P45985, P01589, P31749
|
4.22E-13 |
hsa04066:HIF-1 signaling pathway |
27 |
4.22E-16 |
P23443, P17252, Q02750, P62753, P16885, P04626, P29474, Q9UQM7, P31751, P38936, P42345, P10415, P15260, Q9BUB5, Q13541, P19174, P17948, P05771, P19838, P06730, P08069, Q04206, P00533, Q9UBS0, P46527, P31749, P40763
|
5.55E-13 |
hsa04015:Rap1 signaling pathway |
38 |
4.93E-16 |
P12931, P07333, P11362, P17252, P08581, Q05586, P16234, Q01970, Q02750, P35222, P62158, Q13094, P56945, Q15139, P09619, O60716, P31751, P46108, P46734, P15056, P05556, P19174, P17948, P05771, O43561, P05106, P63000, P10721, P04049, P08069, P35968, P50552, Q9BZL6, Q13224, Q16539, P00533, P31749, Q05513
|
5.55E-13 |
hsa04910:insulin signaling pathway |
31 |
8.97E-16 |
P23443, P19419, O14920, P49815, Q02750, P62753, P10398, P35568, Q12778, P62136, P62158, P36956, O15530, P31751, P17612, P42345, P46108, P29353, P15056, Q13131, P49841, Q92934, Q9BUB5, Q13541, Q05469, P06730, P04049, Q13085, Q9UBS0, P31749, Q05513
|
1.11E-12 |
hsa04662:B cell receptor signaling pathway |
23 |
1.31E-15 |
Q15653, P49841, O14920, P25963, P52735, Q02750, P19838, Q06187, Q8WV28, P63000, O15111, P04049, P05412, P16885, P31751, P43405, Q04206, Q12968, P01100, O00221, Q9Y6K9, P31749, P07948
|
1.67E-12 |
hsa05223:non-small cell lung cancer |
21 |
2.13E-15 |
P06400, P24385, Q13043, Q92934, P17252, Q9UM73, P19174, Q02750, P05771, P10398, O43524, P04637, P04049, O15530, P16885, P04626, P31751, P00533, P31749, P55211, P15056
|
2.64E-12 |
hsa04664:Fc epsilon RI signaling pathway |
22 |
1.21E-14 |
Q9UQC2, P17252, P52735, P19174, Q02750, P05771, Q06187, O43561, P47712, P63000, P04049, Q13094, O15530, P16885, P31751, P43405, P45985, Q16539, O14733, P46734, P31749, P07948
|
1.51E-11 |
hsa05210:colorectal cancer |
21 |
2.07E-14 |
P24385, Q92934, P49841, Q02750, P10398, P84022, P35222, P63000, P04637, O15392, P04049, P05412, Q15796, P31751, P01106, P42574, P01100, P55211, P31749, P15056, P10415
|
2.58E-11 |
hsa04668:TNF signaling pathway |
26 |
3.48E-14 |
P17275, O14920, Q02750, O15111, O43318, Q99683, Q13158, P31751, P01100, P46734, Q9Y6K9, P41279, P18848, P05362, P25963, P15336, P19838, P16220, P05412, Q04206, P45985, P42574, Q16539, O75582, O14733, P31749
|
4.35E-11 |
hsa04931:insulin resistance |
26 |
5.53E-14 |
P23443, O14920, Q12778, P35568, Q02156, P62136, P36956, O15530, P29474, Q06124, P31751, P42345, Q13131, P49841, P25963, Q05655, P19838, P16220, Q15418, Q04759, Q04206, P60484, Q9UBS0, P31749, P40763, Q05513
|
6.92E-11 |
hsa04150:mTOR signaling pathway |
20 |
6.91E-14 |
Q13131, Q15831, P23443, P17252, O14920, P49815, Q13541, P62753, P05771, P35568, P06730, Q96B36, Q15418, O15530, P31751, P42345, P60484, Q9UBS0, P31749, P15056
|
8.66E-11 |
hsa05206:microRNAs in cancer |
41 |
7.89E-14 |
P24385, P17252, O14920, P08581, P16234, Q02750, P35568, Q02156, P15311, Q00987, P38398, P09619, P16885, P04626, P29966, P30305, P30304, P38936, P01106, P42345, P46108, P30307, P29353, P10415, O43521, P24864, P19174, P05771, P19838, P00519, P05106, P04637, P04049, P16949, P42574, P21860, O75582, P60484, P00533, P46527, P40763
|
9.86E-11 |
hsa05213:endometrial cancer |
19 |
1.07E-13 |
P24385, Q92934, P49841, P19419, Q02750, P10398, P35222, O43524, P04637, P04049, O15530, P04626, P31751, P01106, P60484, P00533, P55211, P31749, P15056
|
1.34E-10 |
hsa05162:measles |
28 |
1.60E-13 |
P24385, P42224, P67870, P42229, O15111, O43318, O60674, P51692, P31751, P30281, P15260, P23458, P49841, Q15653, P25963, P24864, P19525, P24941, P19838, Q99704, P04637, Q04759, P52630, Q04206, P01589, P40763, P46527, P31749
|
2.00E-10 |
hsa04064:NF-kappa B signaling pathway |
23 |
2.76E-13 |
P06239, P05362, O14920, P25963, P67870, P19174, P19838, Q06187, O43561, Q8WV28, O15111, O43318, Q07817, Q04759, Q01201, P43403, P16885, P43405, P98170, Q04206, Q9Y6K9, P07948, P10415
|
3.45E-10 |
hsa05145:toxoplasmosis |
26 |
4.81E-13 |
P42224, O14920, O15111, O43318, O60674, O15530, Q13651, P31751, P46734, Q9Y6K9, P55211, P10415, P15260, P23458, P05556, Q15653, Q92934, P25963, P19838, Q07817, Q04206, P98170, P42574, Q16539, P40763, P31749
|
6.02E-10 |
hsa04110:cell cycle |
26 |
1.58E-12 |
P06400, P24385, O14757, Q92769, P49841, P24864, O96017, P00519, P24941, P84022, P50613, P78527, P04637, Q13547, P14635, Q15796, Q00987, Q14683, P30305, P30304, P01106, P38936, P30281, P30307, P46527, P63104
|
1.97E-09 |
hsa04370:VEGF signaling pathway |
19 |
2.46E-12 |
P12931, Q92934, P17252, P19174, Q02750, P05771, P47712, P63000, P04049, P35968, Q05397, P49023, P16885, P29474, P31751, Q16539, P04792, P31749, P55211
|
3.08E-09 |
hsa04210:apoptosis |
19 |
3.35E-12 |
Q92934, O14920, P25963, P19838, O15111, P04637, Q07817, P31751, Q13158, P98170, Q04206, P26951, P42574, P55957, Q9Y6K9, P31749, P55211, P55212, P10415
|
4.19E-09 |
hsa05218:melanoma |
20 |
4.13E-12 |
P06400, P24385, Q92934, P11362, P08581, P16234, Q02750, P10398, O75030, P04637, P08069, P04049, Q00987, P09619, P31751, P38936, P60484, P00533, P31749, P15056
|
5.16E-09 |
hsa04917:prolactin signaling pathway |
20 |
4.13E-12 |
P24385, P42224, P12931, P49841, Q02750, P19838, P42229, O43524, P04049, P07101, P03372, O60674, P51692, P31751, Q04206, Q16539, P01100, P31749, P40763, P29353
|
5.16E-09 |
hsa05231:choline metabolism in cancer |
23 |
7.19E-12 |
P23443, P17252, P16234, P19174, P49815, Q13541, Q02750, P05771, P47712, P63000, P04049, Q13393, P05412, Q92558, O15530, P09619, P31751, P42345, P08047, P00533, P01100, Q9UBS0, P31749
|
8.99E-09 |
hsa05014:amyotrophic lateral sclerosis (ALS) |
17 |
1.05E-11 |
P29466, Q92934, Q05586, P04040, P42262, P63000, P04637, P42261, Q07817, Q99683, P42574, P55957, Q16539, Q13224, P46734, P55211, P10415
|
1.32E-08 |
hsa05120:epithelial cell signaling in Helicobacter pylori infection |
19 |
1.44E-11 |
Q13153, P12931, O14920, P25963, P08581, P19174, P19838, P63000, O15111, P05412, P16885, Q06124, Q04206, P45985, P42574, Q16539, P00533, Q9Y6K9, P07948
|
1.80E-08 |
hsa05222:small cell lung cancer |
21 |
1.48E-11 |
P06400, P24385, P05556, O14920, P25963, P24864, P19838, P24941, O15111, P04637, Q07817, Q05397, P31751, P98170, Q04206, P01106, P60484, Q9Y6K9, P55211, P31749, P10415
|
1.86E-08 |
hsa04650:natural killer cell mediated cytotoxicity |
24 |
5.50E-11 |
P15260, P20963, P06239, Q13153, Q14289, P05362, P17252, P52735, P19174, Q02750, P05771, P10398, O43561, P63000, P04049, Q13094, P43403, P16885, P43405, Q06124, P42574, P55957, P29353, P15056
|
6.88E-08 |
hsa04912:GnRH signaling pathway |
21 |
5.67E-11 |
P18848, P12931, P19419, Q14289, P17252, Q01970, Q02750, P05771, Q05655, P47712, P62158, P04049, Q13393, P05412, Q9UQM7, P45985, Q16539, P17612, O14733, P00533, P46734
|
7.10E-08 |
hsa04720:long-term potentiation |
18 |
1.13E-10 |
P18848, P17252, Q05586, Q02750, Q01970, P05771, P10398, P42262, Q16566, P62136, P62158, P42261, P04049, Q15418, Q9UQM7, Q13224, P17612, P15056
|
1.41E-07 |
hsa05031:amphetamine addiction |
18 |
1.13E-10 |
P18848, P17252, Q05586, P15336, P05771, P42262, Q16566, P62136, P62158, P16220, P42261, P05412, P07101, Q9UQM7, Q13224, P17612, P01100, P53539
|
1.41E-07 |
hsa04920:adipocytokine signaling pathway |
18 |
3.10E-10 |
Q13131, Q15831, Q15653, O14920, P25963, P19838, P35568, O15111, Q04759, O60674, P31751, Q06124, Q04206, P42345, Q9Y6K9, O00221, P31749, P40763
|
3.88E-07 |
hsa05160:hepatitis C |
24 |
3.39E-10 |
P23458, P42224, Q92934, P49841, O14920, P25963, P19525, P19838, P10398, O15111, P04637, P04049, O15551, O15530, P52630, P31751, Q04206, P38936, Q16539, P00533, Q9Y6K9, P31749, P40763, P15056
|
4.24E-07 |
hsa04152:AMPK signaling pathway |
23 |
3.62E-10 |
Q13131, Q15831, P24385, P23443, P49815, Q13541, Q12778, P35568, P16220, Q05469, O43524, O43318, Q96B36, P08069, Q13085, P36956, O15530, P31751, O00418, P37231, P42345, Q9UBS0, P31749
|
4.54E-07 |
hsa05164:influenza A |
27 |
6.37E-10 |
P29466, P42224, P17252, O14920, Q02750, O60674, P31751, P46734, P55211, P15260, P23458, P49841, Q15653, P05362, P25963, P19525, P15336, P05771, P19838, P04049, P05412, P52630, Q04206, P45985, Q16539, O14733, P31749
|
7.97E-07 |
hsa05034:alcoholism |
27 |
9.33E-10 |
Q92769, Q9UBN7, O15379, Q05586, Q02750, Q71DI3, P10398, P62158, P62136, Q13547, P84243, P07101, P56524, P29353, P15056, P16104, P18848, P15336, Q16566, P16220, P04049, Q16620, Q9UQL6, Q9BY41, P68431, Q13224, P53539
|
1.17E-06 |
hsa05219:bladder cancer |
14 |
1.10E-09 |
P06400, P24385, P12931, Q02750, P10398, P04637, P04049, Q00987, P04626, P01106, P38936, O75582, P00533, P15056
|
1.38E-06 |
hsa05202:transcriptional misregulation in cancer |
26 |
1.52E-09 |
P07333, Q92769, P08581, Q15797, Q71DI3, Q12778, Q13547, P84243, Q00987, P38936, P01106, P37231, Q04864, P18846, P17948, P17844, P19838, P04637, P08069, Q07817, Q06413, Q05397, P68431, Q04206, P08047, P46527
|
1.90E-06 |
hsa04071:sphingolipid signaling pathway |
22 |
1.65E-09 |
Q9UQC2, P17252, Q02750, Q01970, P05771, P19838, Q02156, P63000, P04637, P04049, Q13393, Q99683, O15530, P29474, P31751, Q04206, P55957, Q16539, P60484, P31749, Q05513, P10415
|
2.06E-06 |
hsa04915:estrogen signaling pathway |
20 |
2.03E-09 |
P18848, P12931, P15336, Q01970, Q02750, Q05655, P16220, P62158, P04049, P05412, P03372, P08238, P29474, P31751, P17612, P08047, P01100, P00533, P31749, P29353
|
2.54E-06 |
hsa04921:oxytocin signaling pathway |
25 |
2.15E-09 |
Q13131, P24385, P12931, P19419, P17252, Q01970, Q02750, P05771, Q16566, Q92736, P47712, P62158, P62136, P04049, P05412, Q14012, Q06413, P29474, Q9UQM7, O00418, P38936, Q12968, P17612, P00533, P01100
|
2.69E-06 |
hsa05131:shigellosis |
16 |
6.03E-09 |
P18206, P12931, P05556, Q15653, O14920, P25963, P19838, P00519, O15111, P63000, Q92558, Q04206, Q16539, P46108, Q9Y6K9, Q14247
|
7.55E-06 |
hsa05230:central carbon metabolism in cancer |
16 |
6.03E-09 |
P11362, P08581, P16234, Q02750, P04637, P10721, P04049, P09619, P04626, P31751, P01106, P42345, P60484, P00533, P07949, P31749
|
7.55E-06 |
hsa04620:toll-like receptor signaling pathway |
20 |
6.73E-09 |
P41279, P42224, O14920, P25963, Q02750, P19838, P63000, O15111, O43318, P05412, P31751, Q13158, Q04206, P45985, Q16539, O14733, P01100, Q9Y6K9, P46734, P31749
|
8.42E-06 |
hsa04670:leukocyte transendothelial migration |
21 |
7.30E-09 |
P18206, P05556, Q14289, P05362, P17252, P16284, P52735, P19174, P05771, P35222, P63000, O15551, P56945, P50552, P15311, Q05397, P49023, P16885, O60716, Q06124, Q16539
|
9.13E-06 |
hsa04630:Jak-STAT signaling pathway |
23 |
1.07E-08 |
P24385, P15260, P24394, P23458, P42224, P78552, P42226, P42229, Q07817, P19235, O60674, P52630, O75886, P51692, Q13651, P31751, Q06124, P26951, P01589, P01106, P30281, P31749, P40763
|
1.33E-05 |
hsa04024:cAMP signaling pathway |
27 |
1.07E-08 |
Q05586, Q02750, P42262, P62158, P62136, Q9UQM7, P31751, P17612, P01100, P15056, Q13153, Q92934, P25963, P52735, P19838, Q16566, Q92736, Q05469, P63000, P16220, P42261, P04049, Q13393, P05412, Q04206, Q13224, P31749
|
1.34E-05 |
hsa04810:regulation of actin cytoskeleton |
27 |
4.08E-08 |
P18206, P12931, P11362, P16234, Q02750, P10398, P23528, P62136, P56945, P15311, P09619, P53667, O75914, P46108, P15056, P05556, Q13153, P52735, P16144, Q13177, P05106, P63000, P04049, Q92558, Q05397, P49023, P00533
|
5.10E-05 |
hsa05211:renal cell carcinoma |
15 |
6.24E-08 |
Q13153, P08581, Q02750, Q13177, P10398, P63000, P04049, Q13480, P05412, P31751, Q06124, O75914, P46108, P31749, P15056
|
7.81E-05 |
hsa04115:p53 signaling pathway |
15 |
9.37E-08 |
P24385, O14757, P24864, P49815, O96017, P24941, P04637, P14635, Q00987, P38936, P42574, P55957, P60484, P30281, P55211
|
1.17E-04 |
hsa05100:bacterial invasion of epithelial cells |
16 |
1.04E-07 |
P18206, P12931, P05556, P08581, P35222, Q03135, P63000, Q05193, Q13480, Q92558, P56945, Q05397, P49023, P46108, P29353, Q14247
|
1.30E-04 |
hsa04925:aldosterone synthesis and secretion |
16 |
1.76E-07 |
P18846, P18848, P17252, P15336, Q01970, P05771, Q16566, Q02156, Q05469, P62158, P16220, Q14012, Q15139, Q9UQM7, Q9BZL6, P17612
|
2.20E-04 |
hsa05142:Chagas disease (American trypanosomiasis) |
18 |
1.76E-07 |
P15260, P20963, O14920, P25963, Q01970, P19838, P84022, O15111, P05412, Q15796, P31751, Q13158, Q04206, P45985, Q16539, P01100, Q9Y6K9, P31749
|
2.21E-04 |
hsa04520:adherens junction |
15 |
2.02E-07 |
P18206, P12931, P11362, P08581, P67870, P84022, P35222, P63000, O43318, P08069, Q92558, Q15796, P04626, O60716, P00533
|
2.53E-04 |
hsa05152:tuberculosis |
23 |
4.11E-07 |
P15260, P42224, P23458, P12931, Q92934, P19838, P16220, P62158, P04049, O60674, Q13651, P31751, Q9UQM7, P43405, Q13158, Q04206, P42574, Q8IVT5, P55957, Q16539, P55211, P31749, P10415
|
5.14E-04 |
hsa04914:progesterone-mediated oocyte maturation |
16 |
4.67E-07 |
Q02750, P24941, P10398, P08069, Q15418, P14635, P04049, P08238, P31751, P30305, P30304, Q16539, P17612, P30307, P31749, P15056
|
5.85E-04 |
hsa05168:herpes simplex infection |
23 |
7.36E-07 |
P15260, P42224, P23458, Q15653, O14920, P25963, P19525, P67870, P19838, P24941, O15111, P62136, P04637, O43318, P05412, O60674, P52630, Q13158, Q06124, Q04206, P42574, P01100, Q9Y6K9
|
9.21E-04 |
hsa04728:dopaminergic synapse |
19 |
7.83E-07 |
P18848, P49841, P17252, P15336, Q01970, P05771, P42262, P62136, P62158, P16220, P42261, P07101, P31751, Q9UQM7, Q13224, Q16539, P17612, P01100, P31749
|
9.80E-04 |
hsa05030:cocaine addiction |
12 |
1.08E-06 |
P05412, P07101, P18848, Q04206, Q05586, P15336, P17612, Q13224, P19838, P42262, P53539, P16220
|
0.0013532 |
hsa05140:Leishmaniasis |
14 |
1.36E-06 |
P15260, P42224, P23458, P05556, Q15653, P19419, P25963, P19838, O43318, P05412, O60674, Q04206, Q16539, P01100
|
0.0017044 |
hsa04750:inflammatory mediator regulation of TRP channels |
16 |
2.26E-06 |
P12931, P17252, P19174, Q01970, P05771, Q05655, P47712, P62136, P62158, Q02156, Q04759, P16885, Q9UQM7, Q16539, P17612, P46734
|
0.0028271 |
hsa04611:platelet activation |
18 |
4.45E-06 |
P05556, P12931, Q01970, Q06187, P05106, P47712, P62136, Q13094, P50552, P16885, P29474, P31751, P43405, Q16539, P17612, P31749, Q05513, P07948
|
0.0055652 |